Sign inJoin waitlistJoin the waitlist

Rajni Sinha

Physician · Piedmont Cancer Institute PC

Credentials: · · · · · ·

History

Piedmont Cancer Institute PC
Present

Hematology and Medical Oncology
2002–2005
Internal Medicine
1999–2002
Doctor of Medicine
1995–1999

Research

Inhibition of Syk with fostamatinib disodium has significant clinical activity in non-Hodgkin lymphoma and chronic lymphocytic leukemia
Blood · 2010 · 618 citations
Nanotechnology in cancer therapeutics: bioconjugated nanoparticles for drug delivery
Review · Molecular Cancer Therapeutics · 2006 · First of 4 authors · 429 citations
Trastuzumab deruxtecan versus treatment of physician's choice in patients with HER2-positive metastatic breast cancer (DESTINY-Breast02): a randomised, open-label, multicentre,…
The Lancet · 2023 · 327 citations

Christopher Flowers
30 papers
Loretta Nastoupil
12 papers · 12 as a fellow
Sagar Lonial
11 papers
Mary Lechowicz
10 papers
Jonathan Kaufman
8 papers · 1 as a fellow
Ajay Nooka
7 papers · 3 as a fellow
Amelia Langston
6 papers
Edmund Waller
6 papers
Nassoma King
6 papers
Jonathan Friedberg
5 papers
BL
Brian Link
4 papers
HK
Hanna Khoury
4 papers

Clinical trials

A Phase I Trial Using Cyclophosphamide, Rituximab and Revlimid (CR2) for the Treatment of Relapsed/Refractory B-Cell Chronic Lymphocytic Leukemia (B-CLL) and Small Lymphocytic Lymphoma (SLL)
Principal investigator · Terminated · Phase 1
Emory University
2010